Dumayo, William B.
HRN: 09-87-17 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/19/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/19/2022
10/26/2022
IV INFUSION
4.5g
Q6
Elevated WBC, CVA Tenderness, Fever
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes